Related Experiment Video

Updated: Jun 18, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.0K

Correction: Brain targeted delivery of rapamycin using transferrin decorated nanostructured lipid carriers

Fatemeh Khonsari1, Mostafa Heydari2, Rassoul Dinarvand3

  • 1Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Bioimpacts : BI
|January 16, 2023
PubMed

Abstract:

[This corrects the article DOI: 10.34172/bi.2021.23389.].

More Related Videos

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

10.6K
Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
09:36

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Published on: February 5, 2019

8.8K

Related Experiment Videos

Last Updated: Jun 18, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.0K
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

10.6K
Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
09:36

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo

Published on: February 5, 2019

8.8K

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Articles linked to this work by shared authors, journal, and citation graph.

Non-invasive detection of choroidal melanoma via tear-derived protein corona on gold nanoparticles: a machine learning approach.

Scientific reports·2025

Innovative triamcinolone acetonide microsuspension for Non-Invasive ocular management of inflammation.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences·2025

Co-delivery of SN38 and rapamycin albumin bound nanoparticles against breast Cancer.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences·2025

Effect of nanomicelle morphology on peptide activity and ROS generation for enhancing chemotherapy efficacy in breast cancer.

Biomaterials science·2025

Carbon dots with red emission as nanoprobe for sensing of heparin in biofluids and pharmaceutical samples.

RSC advances·2025

Charge neutralized poly(β-amino ester) polyplex nanoparticles for delivery of self-amplifying RNA.

Nanoscale advances·2024

Designing a multi-epitope vaccine against dengue virus-2 using in silico tools for expression in plant systems.

BioImpacts : BI·2026

Short interference RNAs in glomerulonephritis: A mini review.

BioImpacts : BI·2026

Correction to: Sustained release microneedle patch for pronounced systemic delivery of doxazosin mesylate.

BioImpacts : BI·2026

An integrative computational strategy for antidiabetic drug discovery: From QSAR modeling to retrosynthesis.

BioImpacts : BI·2026

Naphthoquinones mediate differentiation of human umbilical cord derived mesenchymal stem cells into insulin producing cells through regulation of Wnt and BMP pathways.

BioImpacts : BI·2026

Transcriptomics and single-cell RNA sequencing uncover prognostic characteristics and immune regulatory mechanisms of lactylation in cervical cancer.

BioImpacts : BI·2026

Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.

Journal of the American College of Cardiology·2026

Gene Silencer Therapy in Transthyretin Amyloid Cardiomyopathy: A Meta-Analysis of Outcomes Trials.

JAMA·2026

Advanced therapy medicinal products in Saudi Arabia: Regulation and development.

Regenerative therapy·2026

289th ENMC international workshop: assessing and managing emerging AAV related toxicities after gene therapy for neuromuscular disorders, 26 - 28 September 2025, Hoofddorp, The Netherlands.

Neuromuscular disorders : NMD·2026

ADHERENCE PATTERNS AND THEIR DETERMINANTS TO CFTR MODULATORS IN FRANCE.

Respiratory medicine·2026

Photobiomodulation therapy in the management of chronic wounds: From molecular mechanisms to translational clinical evidence.

Biochimie·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us